Diego Saavedra
Internal Medicine · Miami, FLNPI 1689643850
Payments from drug & device makers
Across 342 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$800
- Novo Nordisk$572
- Lilly USA, LLC$553
- AstraZeneca$447
- Pfizer$437
- Abbott$432
- plus $3K from 34 others
What the payments were for
- Food & beverage$6,069100%
- Education$170%
- Gifts$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 44 | $800 |
| Novo Nordisk | 27 | $572 |
| Lilly USA, LLC | 37 | $553 |
| AstraZeneca | 28 | $447 |
| Pfizer | 27 | $437 |
| Abbott | 21 | $432 |
| GSK | 22 | $407 |
| Amarin Pharma, Inc. | 15 | $362 |
| AbbVie(2 entities) | 17 | $229 |
| Nestle Healthcare Nutrition Inc. | 13 | $212 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $169 |
| Boehringer Ingelheim | 9 | $163 |
| Novartis | 9 | $148 |
| Merck | 7 | $120 |
| Exact Sciences | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 5 | $82 |
| Johnson & Johnson | 4 | $80 |
| Biohaven Pharmaceuticals, Inc. | 3 | $72 |
| Dexcom, Inc. | 4 | $67 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Sanofi Pasteur Inc. | 3 | $60 |
| Bayer | 3 | $56 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Lifescan, Inc. | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $40 |
| Optinose US, Inc. | 2 | $35 |
| Medtronic | 2 | $34 |
| Astellas Pharma US Inc | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Edwards Lifesciences | 1 | $26 |
| Curonix LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,100 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $31,120 |
| FarxigaDapagliflozin Propanediol | 26 | $28,522 |
| MounjaroTirzepatide | 26 | $27,210 |
| OzempicSemaglutide | 12 | $17,271 |
| TradjentaLinagliptin | 14 | $15,341 |
| XareltoRivaroxaban | 12 | $13,122 |
| Atorvastatin Calcium | 618 | $6,476 |
| SynthroidLevothyroxine Sodium | 51 | $6,123 |
| Levothyroxine Sodium | 377 | $4,369 |
| Omeprazole | 155 | $4,121 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,876 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,819 |
| Amlodipine Besylate | 262 | $2,133 |
| Gabapentin | 68 | $1,658 |
| Losartan Potassium | 122 | $1,639 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $447 | $31,39938 claims |
| PfizerEliquis | $437 | $31,12023 claims |
| Lilly USA, LLCMounjaro | $553 | $27,21026 claims |
| Novo NordiskOzempic | $572 | $17,27112 claims |
| Boehringer IngelheimTradjenta | $163 | $15,34114 claims |
| Johnson & JohnsonXarelto | $80 | $13,12212 claims |
| AbbVieSynthroid | $229 | $6,12351 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $4,369377 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami
- Mark KutnerMiami$35.7M
- Mercedes Ponce de LeonMiami$6.8M
- Alejandro de la CruzMiami$6.2M
- Roberto SotolongoMiami$5.8M
- Enrique PelayoMiami$5.4M
- Renato DominguezMiami$5.2M
- Ramses VegaMiami$4.4M
- Dunia Llapur HernandezMiami$4.3M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.